Litcius/Paper detail

Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial

Esaú João, R. L. Morrison, David E. Shapiro, Nahida Chakhtoura, Maria Isabel S. Gouvea, Maria de Lourdes Benamor Teixeira, Trevon Fuller, Blandina T. Mmbaga, James S. Ngocho, Boniface Njau, Avy Violari, Ruth Mathiba, Zaakirah Essack, José Henrique Pilotto, Luíz Felipe Pinho Moreira, María José Rolón, Pedro Cahn, Sinart Prommas, Tim R. Cressey, Kulkanya Chokephaibulkit, Peerawong Werarak, Lauren Laimon, Roslyn Hennessy, Lisa M. Frenkel, Patricia Anthony, Brookie M. Best, George K. Siberry, Mark Mirochnick

2020The Lancet HIV46 citationsDOIOpen Access PDF

Topics & Concepts

EfavirenzRaltegravirMedicineRegimenViral loadLamivudineEmtricitabineIntegrase inhibitorInternal medicineRilpivirineVirologyHuman immunodeficiency virus (HIV)Antiretroviral therapyVirusHepatitis B virusHIV/AIDS drug development and treatmentHIV/AIDS Research and InterventionsHIV-related health complications and treatments